As of Oct 09
| -1.21 / -6.24%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 36.00 and a low estimate of 25.00. The median estimate represents a +53.93% increase from the last price of 18.19.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.